Enter your keyword

PUBLICATIONS

Publications by the NI3D group in the last five years

A. Herraiz, A. Rodríguez-San-Pedro, […], J. Pellico, F. Herranz. A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator. npj Imaging 2026, 4, 8.
Scheme 1 : Radiolabeling approaches.
Nogales, P.; Muñoz-Hernando, M.; Bentzon, J.F.; Herranz, F.; Pellico, P. Targeted PET Imaging of Atherosclerosis via Low-Density Lipoprotein Click Chemistry with Nanoparticles. Chem. Biomed. Imaging 2025, in press.
Muñoz-Hernando, M.; Nogales, P.; Rodríguez-San Pedro, A.; Ibañez, M.; Morcillo, M.A.; González-Cintado, L.; Bentzon, J.F.; Herranz, F. Nanoparticle to Nanoparticle Bioorthogonal Detection of Atherosclerosis ACS Appl. Mater. Interfaces 2025, 17, 41, 56675–56686

Arroyo-Urea, E. M.; Lázaro-Díez, M.; Garmendia, J.; Herranz, F.; González-Paredes, A. Lipid-Based Nanomedicines for the Treatment of Bacterial Respiratory Infections: Current State and New Perspectives. Nanomedicine, 2024, nnm-2023-0243.

Malarz, K.; Korzuch, J.; Mrozek-Wilczkiewicz, A.; Szubka, M.; Rurka, P.; Małota, K.; Herraiz, A.; Dreszer, D.; Kocot, K.; Herranz, F.; Rost-Roszkowska, M.; Sun, T.; Musioł, R.;  Serda, M. Aminofullerenes as Targeted Inhibitors of EGFR: From Pancreatic Cancer Inhibitors to Drosophila m . ToxicologyNanomedicine 2025, 20, n.o 6: 585-601

Nué-Martinez, J.J,; Leo-Barriga, M.; Herranz, F.; Koutsogiannis, Z.; Denny, P.W.; Ebiloma, G.U.; Dardonville, C.; González-Paredes, A.. Nanostructured Lipid Carrier for Intracellular Delivery of a Bis(Pyridine-2-Carboxamidine) DNA Minor Groove Binder Active against Leishmania. ACS Omega, 2025, 10, 7795-805.

Asensio-López, J.; Lázaro-Díez, M.; Hernández-Cruz, T.M.; Blanco-Cabra, N.; Sorzabal-Bellido, I.; Arroyo-Urea, E. M.; Buetas, E.; et al. Multimodal Evaluation of Drug Antibacterial Activity Reveals Cinnamaldehyde Analog Anti-Biofilm Effects against Haemophilus Influenzae. Biofilm 2024, 7, 100178.

Fernández-Villa, D.; Herraiz, A.: De Wit, K.; Herranz, F.;  Aguilar, M.R.; Rojo, L. Design of Tunable Hyaluronic Acid and O′-Carboxymethyl Chitosan Formulations for the Minimally Invasive Delivery of Multifunctional Therapies Targeting Rheumatoid Arthritis. Carbohydrate Polymers, 2025, 349: 123018.

Muñoz-Hernando, M.; Nogales, P.; Fernández-Barahona, I.; Ruiz-Cabello. J.; Bentzon J. F.; Herranz, F. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosisNanoscale2024, 10.1039/D3NR06507C.

Article featured as issue cover:

Ibáñez-Moragues, M.; Fernández-Barahona, I.; Santacruz, R.; Oteo, M.; Luján-Rodríguez, V. M.; Muñoz-Hernando, M.; Magro, N. et al. Zinc-Doped Iron Oxide Nanoparticles as a Proton-Activatable Agent for Dose Range Verification in Proton Therapy. Molecules 2023, 28, 19, 6874.

Martínez-Parra, L.; Piñol-Cancer, M.; Sanchez-Cano, C.; Miguel-Coello, A.B.; Di Silvio, D.; Gomez, A.M.; Uriel, C. et al. A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque. ACS Nano 2023, 17, 14, 13811.

Pellico, J.; Ruiz-Cabello, J.; Herranz, F. Radiolabeled Iron Oxide Nanomaterials for Multimodal Nuclear Imaging and Positive Contrast Magnetic Resonance Imaging (MRI): A Review. ACS Applied Nano Materials 2023, 6, 22, 20523.

Ceron, C.; Casquero‐Veiga, M.; Fernandez‐Barahona, I.; Muñoz‐Hernando, M.; Fernandez‐Nueda, I., Fuster, V., Moro, M.A.; Herranz, F.; Cortes‐Canteli, M. In Vivo Nanotracer for the Detection of Brain Thrombi in an AD Mouse Model. Alzheimer’s & Dementia 2023, 19, S16: e073660.

Arroyo-urea, E. M.; Muñoz-Hernando, M.; Leo-Barriga, M.; Herranz, F.; González-Paredes, A. A quality by design approach for the synthesis of palmitoyl carnitine loaded nanoemulsions as drug delivery systems. Drug Delivery2023, 30, 1, 2179128.

Martí-María, O.; Martínez-Gualda, B.; Fernández-Barahona, I.; Mills, A.; Abdelnabi; R.; Noppen, S.; Neyts, J.; Schols, D.; Camarasa, M.J.; Herranz, F.; Gago, F.; San-Félix, A. Organotropic dendrons with high potency as HIV-1, HIV-2 and EV-A71 cell entry inhibitors. Eur. J. Med. Chem. 2022, 237, 114414.

Grzelak, J.; Gázquez, J.; Grayston, A.;  Teles, M.; Herranz, F.; Roher, N.; Rosell, A.; Roig, A., Gich, M. Magnetic Mesoporous Silica Nanorods Loaded with Ceria and Functionalized with Fluorophores for Multimodal Imaging. ACS Appl. Nano Mater. 2022, 5, 2, 2113.

Carregal-Romero, S.; Groult, H.; Cañadas, O.; Gonzalez, N.; Lechuga-Vieco, A..; García-Fojeda, B.; Herranz, F.; Pellico, J.; Hidalgo, A.; Casals, C.; Ruiz-Cabello, J. Delayed alveolar clearance of nanoparticles through control of coating composition and interaction with lung surfactant protein A  Biomaterials Advances 2022, 112551

Pellico, J.; Fernández-Barahona, I.; Ruiz-Cabello, J.; Gutiérrez, L.; Muñoz-Hernando, M.; Sánchez-Guisado, M.J.; Aiestaran-Zelaia, I.; Martínez-Parra, L.; Rodríguez, I.; Bentzon, J. and Herranz, F. HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis. ACS Applied Materials & Interfaces 2021, 13, 45279−45290.

Article featured as issue cover:

Díez-Villares, S.; Pellico, J.; Gómez-Lado, N.; Grijalvo, S.; Alijas, S.; Eritja, R.; Herranz, F.; Aguiar, P.; de la Fuente, M. Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging. International J. of Nanomedicine 2021 :16 5923–5935

Mazarío, E.; Cañete, M.; Herranz, F.; Sánchez-Marcos, J.; de la Fuente, J.M.; Herrasti, P. and Menéndez, N. Highly Efficient T2 Cobalt Ferrite Nanoparticles Vectorized for Internalization in Cancer CellsPharmaceuticals2021, 14, 124.

Cogliati, S.; Herranz, F.; Ruiz-Cabello, J.; Enríquez, J. A. Digitonin concentration is determinant for mitochondrial supercomplexes analysis by BlueNative PageBBA – Bioenergetics2021, 1862, 148332.

Publications in previous years can be found here and here